160 related articles for article (PubMed ID: 12792752)
1. Extracellular matrix remodeling may predominate over hepatocyte injury in hepatocellular carcinoma development.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Fukui H
Oncol Rep; 2003; 10(4):957-62. PubMed ID: 12792752
[TBL] [Abstract][Full Text] [Related]
2. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Sakaida I; Matsumura Y; Akiyama S; Hayashi K; Ishige A; Okita K
J Hepatol; 1998 Feb; 28(2):298-306. PubMed ID: 9514543
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Kawaguchi K; Sakaida I; Tsuchiya M; Omori K; Takami T; Okita K
Biochem Biophys Res Commun; 2004 Feb; 315(1):187-95. PubMed ID: 15013444
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis accelerates the development of enzyme-altered lesions in the rat liver.
Sakaida I; Hironaka K; Uchida K; Suzuki C; Kayano K; Okita K
Hepatology; 1998 Nov; 28(5):1247-52. PubMed ID: 9794908
[TBL] [Abstract][Full Text] [Related]
5. Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Sakaida I; Tsuchiya M; Kawaguchi K; Kimura T; Terai S; Okita K
J Hepatol; 2003 Jun; 38(6):762-9. PubMed ID: 12763369
[TBL] [Abstract][Full Text] [Related]
6. Effects of lycopene and Sho-saiko-to on hepatocarcinogenesis in a rat model of spontaneous liver cancer.
Watanabe S; Kitade Y; Masaki T; Nishioka M; Satoh K; Nishino H
Nutr Cancer; 2001; 39(1):96-101. PubMed ID: 11588908
[TBL] [Abstract][Full Text] [Related]
7. Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation.
Shiota G; Maeta Y; Mukoyama T; Yanagidani A; Udagawa A; Oyama K; Yashima K; Kishimoto Y; Nakai Y; Miura T; Ito H; Murawaki Y; Kawasaki H
Hepatology; 2002 May; 35(5):1125-33. PubMed ID: 11981762
[TBL] [Abstract][Full Text] [Related]
8. Potential inhibitory effects of D-allose, a rare sugar, on liver preneoplastic lesion development in F344 rat medium-term bioassay.
Yokohira M; Hosokawa K; Yamakawa K; Saoo K; Matsuda Y; Zeng Y; Kuno T; Imaida K
J Biosci Bioeng; 2008 May; 105(5):545-53. PubMed ID: 18558347
[TBL] [Abstract][Full Text] [Related]
9. Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
Jin H; Sakaida I; Tsuchiya M; Okita K
Life Sci; 2005 Apr; 76(24):2805-16. PubMed ID: 15808881
[TBL] [Abstract][Full Text] [Related]
10. The copper-chelating agent, trientine, attenuates liver enzyme-altered preneoplastic lesions in rats by angiogenesis suppression.
Yoshiji H; Kuriyama S; Yoshii J; Ikenaka Y; Noguchi R; Yanase K; Namisaki T; Yamazaki M; Tsujinoue H; Imazu H; Fukui H
Oncol Rep; 2003; 10(5):1369-73. PubMed ID: 12883709
[TBL] [Abstract][Full Text] [Related]
11. The role of TGF-beta 1 and cytokines in the modulation of liver fibrosis by Sho-saiko-to in rat's bile duct ligated model.
Chen MH; Chen JC; Tsai CC; Wang WC; Chang DC; Tu DG; Hsieh HY
J Ethnopharmacol; 2005 Feb; 97(1):7-13. PubMed ID: 15652268
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet.
Nakanishi C; Moriuchi A; Ido A; Numata M; Kim ID; Kusumoto K; Hasuike S; Abe H; Nagata K; Akiyama Y; Uto H; Kataoka H; Tsubouchi H
Oncol Rep; 2006 Jul; 16(1):25-31. PubMed ID: 16786119
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats.
Yoshiji H; Yoshii J; Ikenaka Y; Noguchi R; Tsujinoue H; Nakatani T; Imazu H; Yanase K; Kuriyama S; Fukui H
J Hepatol; 2002 Jul; 37(1):22-30. PubMed ID: 12076858
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model.
Perra A; Pibiri M; Sulas P; Simbula G; Ledda-Columbano GM; Columbano A
Carcinogenesis; 2008 Jan; 29(1):161-8. PubMed ID: 17893235
[TBL] [Abstract][Full Text] [Related]
15. Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury.
Powell CL; Kosyk O; Bradford BU; Parker JS; Lobenhofer EK; Denda A; Uematsu F; Nakae D; Rusyn I
Hepatology; 2005 Nov; 42(5):1137-47. PubMed ID: 16250055
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver.
Tamura K; Nakae D; Horiguchi K; Akai H; Kobayashi Y; Satoh H; Tsujiuchi T; Denda A; Konishi Y
Jpn J Cancer Res; 1997 Apr; 88(4):356-62. PubMed ID: 9197526
[TBL] [Abstract][Full Text] [Related]
17. Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.
Kitade M; Yoshiji H; Kojima H; Ikenaka Y; Noguchi R; Kaji K; Yoshii J; Yanase K; Namisaki T; Asada K; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
Hepatology; 2006 Oct; 44(4):983-91. PubMed ID: 17006938
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow-derived cells fuse with hepatic oval cells but are not involved in hepatic tumorigenesis in the choline-deficient ethionine-supplemented diet rat model.
Kubota K; Soeda J; Misawa R; Mihara M; Miwa S; Ise H; Takahashi M; Miyagawa S
Carcinogenesis; 2008 Feb; 29(2):448-54. PubMed ID: 18174248
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient L-amino acid defined diet.
Yoshiji H; Nakae D; Mizumoto Y; Horiguchi K; Tamura K; Denda A; Tsujii T; Konishi Y
Carcinogenesis; 1992 Jul; 13(7):1227-33. PubMed ID: 1638691
[TBL] [Abstract][Full Text] [Related]
20. Combination of vitamin K2 and the angiotensin-converting enzyme inhibitor, perindopril, attenuates the liver enzyme-altered preneoplastic lesions in rats via angiogenesis suppression.
Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Masaki T; Fukui H
J Hepatol; 2005 May; 42(5):687-93. PubMed ID: 15826718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
